期刊文献+

糖尿病患者伴发抑郁焦虑症80例临床分析 被引量:2

下载PDF
导出
摘要 目的了解糖尿病患者伴发抑郁焦虑症的发生率,探讨其对糖尿病的影响。方法采用汉密尔顿焦虑量表(HAMA)和抑郁量表(HAMD)对80例糖尿病患者(观察组)和70名健康者(对照组)进行评分比较。结果观察组患抑郁焦虑症33例,患病率为41.3%;对照组患抑郁焦虑症8例,患病率为11.4%;HAMD评分:观察组(21±5)分,对照组(12±3)分。观察组患病率和HAMD评分均明显高于对照组(P<0.01)。结论抑郁焦虑症在糖尿病患者中发生率较高,对糖尿病的进展及预后都具有不良影响,只有及时处理糖尿病患者的抑郁症状才能提高其生活质量。
作者 王迎连
出处 《基层医学论坛》 2013年第26期3404-3406,共3页 The Medical Forum
  • 相关文献

参考文献4

二级参考文献20

  • 1Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation [ J]. Diabetes Care, 1993,16: 1167-1178.
  • 2Eaton WW, Armenian H, Gallo J, et al. Depression and risk for onset of type Ⅱ diabtes. A prospective population-based study [ J]. Diabetes Care, 1996,19:1097-1102.
  • 3Lustman PJ, Anderson R J, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature [ J ]. Diabetes Care, 2000,23: 934-942.
  • 4Coplan JD, Wolk SI, Goetz RR, et al. Nocturnal growth hormone secretion studies in adolescents with or without major depression re-examined:integration of adult clinical follow-up data [ J ]. Biol Psychiatry, 2000,47: 594-604.
  • 5Birmaher B, Dahl RE, Williamson DE, et al. Growth hormone secretion in childern and adolescents at high risk for major depressive disorder[J].Arch Gen Psychiatry,2000,57:867-872.
  • 6Okamurat F, Tashiro A, Utsumi A, et al. Insulin resistance in patients with depression and its changes in the clinical course of depression:a repert on three cases using the minimal model analysis[ J]. Intern Med ,1999,38: 257-260.
  • 7Mourilhe P, Stock PE. Risk and benefits of selective serotonin reuptake inhibitors in the treatment of depression[J]. Drug Safety, 1998,18: 57-82.
  • 8O'Kane M, Wiles PG, Wales JK. Fluoxetine in the treatment of obese type 2 diabetic patients[ J]. Diabet Med, 1994,11:105-110.
  • 9Takhar J,Williamson P.Hypoglycemia associated with high doses of sertraline and sulphonylurea compound in a noninsulin-dependent diabetes mellitus patient[J]. Can J Clin Pharmacol, 1999,6:12-14.
  • 10Lustman PJ,Griffith LS,Freedland KE,et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomizod, controlled trial [J]. Ann Intern Med, 1998,129:613-621.

共引文献69

同被引文献26

  • 1徐春芳,袁绿化,王巧艳.补心丸治疗产后抑郁症30例疗效观察[J].山东中医杂志,2006,25(1):28-29. 被引量:13
  • 2Anderson PJ,Freedland KE,Clause RE,et al.The prevalence of Colnorbid depression in adults with diabetes:a meta-analysis[J].Diabetes Care,2001,24(6):1 069.
  • 3中华医学会精神病学分会.中国精神疾病分类与诊断标准:第3版[J].中华精神科杂志,2001,34(3):184.
  • 4Buysse DJ,Reynolds CF,Monk TH,et al.T The Pittsburgh Sleep Quality Index:a new instrument for psychiatric practice and research[J].Psychiatry Res,1989,28(2):193.
  • 5Mendlewicz J,Linkowski P,Branchey L,et al.Abnormal 24 hour pattern of melatonin secretion in depression[J].Lancet,1979,2(8156/8 157):1362.
  • 6Crasson M,Kjiri S,Colin A,et al.Serum melatonin and urinary 6-sulfatoxymelatonin in major depression[J].Psychoneuroendocrinology,2004,29(1):1.
  • 7Rahman SA,Marcu S,Kayumov L,et al.Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors[J].Eur Arch Psychiatry Clin Neurosci,2010,260(4):327.
  • 8Serfaty MA,Osborne D,Buszewicz MJ,et al.A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin(6 mg)or placebo for sleep disturbance and depressed mood[J].Int Clin Psychopharmacol,2010,25(3):132.
  • 9Zajecka J,Schatzberg A,Stahl S,et al.Efficacy and safety of agomelatine in the treatment of major depressive disorder:a multicenter,randomized,double-blind,placebocontrolled trial[J].J Clin Psychopharmacol,2010,30(2):135.
  • 10Stahl SM,Fava M,Trivedi MH,et al.Agomelatine in the treatment of major depressive disorder:an 8-week,multicenter,randomized,placebo-controlled trial[J].J Clin Psychiatry,2010,71(5):616.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部